| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.818 | 0.004 | 0.818 | Cardiotonic | 0.782 0.004 CID_9865894 | ||
| 0.725 | 0.005 | 0.725 | Anticonvulsant | 0.638 0.005 CID_9865894 | ||
| 0.582 | 0.006 | 0.582 | Psychostimulant | 0.545 0.008 CID_9865894 | ||
| 0.545 | 0.018 | 0.545 | Spasmolytic | 0.46 0.029 CID_9865894 | ||
| 0.435 | 0.005 | 0.435 | Anesthetic local | 0.356 0.009 CID_9865894 | ||
| 0.399 | 0.047 | 0.399 | Aldehyde oxidase inhibitor | |||
| 0.363 | 0.012 | 0.363 | Lipocortins synthesis antagonist | 0.304 0.02 CID_9865894 | ||
| 0.409 | 0.08 | 0.491 | Analgesic | 0.491 0.052 CID_9865894 | CID_9865894 | |
| 0.357 | 0.035 | 0.375 | Sodium/bile acid cotransporter inhibitor | 0.375 0.026 CID_9865894 | CID_9865894 | |
| 0.391 | 0.069 | 0.391 | Antiobesity | 0.368 0.079 CID_9865894 | ||
| 0.334 | 0.034 | 0.334 | Nitric oxide antagonist | 0.32 0.037 CID_9865894 | ||
| 0.276 | 0.001 | 0.276 | GABA uptake inhibitor | 0.152 0.002 CID_9865894 | ||
| 0.266 | 0.003 | 0.266 | Vasopressin 1B antagonist | 0.226 0.004 CID_9865894 | ||
| 0.257 | 0.004 | 0.257 | Vasopressin 1 antagonist | 0.203 0.005 CID_9865894 | ||
| 0.256 | 0.004 | 0.256 | Oxytocin antagonist | 0.223 0.004 CID_9865894 | ||
| 0.252 | 0.009 | 0.252 | Acetylcholine nicotinic antagonist | 0.225 0.011 CID_9865894 | ||
| 0.37 | 0.13 | 0.37 | Caspase 9 stimulant | 0.276 0.221 CID_9865894 | ||
| 0.242 | 0.02 | 0.244 | 5 Hydroxytryptamine 3E antagonist | 0.244 0.019 CID_9865894 | CID_9865894 | |
| 0.305 | 0.088 | 0.321 | Cholesterol antagonist | 0.321 0.079 CID_9865894 | CID_9865894 | |
| 0.218 | 0.004 | 0.218 | Vasopressin 1A antagonist | 0.168 0.004 CID_9865894 | ||
| 0.208 | 0.005 | 0.208 | Antidiuretic hormone antagonist | 0.166 0.006 CID_9865894 | ||
| 0.249 | 0.049 | 0.249 | Sigma receptor agonist | |||
| 0.248 | 0.051 | 0.248 | Anesthetic general | 0.15 0.113 CID_9865894 | ||
| 0.21 | 0.024 | 0.21 | Arachidonic acid antagonist | 0.166 0.07 CID_9865894 | ||
| 0.195 | 0.01 | 0.209 | Opioid kappa receptor antagonist | 0.209 0.009 CID_9865894 | CID_9865894 | |
| 0.201 | 0.019 | 0.201 | Nav1.1 sodium channel blocker | 0.144 0.036 CID_9865894 | ||
| 0.18 | 0.005 | 0.18 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.154 0.005 CID_9865894 | ||
| 0.188 | 0.019 | 0.188 | 5 Hydroxytryptamine 2C antagonist | 0.133 0.031 CID_9865894 | ||
| 0.268 | 0.126 | 0.358 | Calcium channel activator | 0.358 0.045 CID_9865894 | CID_9865894 | |
| 0.172 | 0.033 | 0.172 | Nav1.6 sodium channel blocker | 0.141 0.065 CID_9865894 | ||
| 0.177 | 0.039 | 0.177 | Cholinergic antagonist | 0.131 0.064 CID_9865894 | ||
| 0.169 | 0.036 | 0.203 | Adenylate cyclase stimulant | 0.203 0.012 CID_9865894 | CID_9865894 | |
| 0.255 | 0.124 | 0.255 | Vasodilator, peripheral | |||
| 0.163 | 0.033 | 0.163 | Pregnane X receptor agonist | 0.152 0.05 CID_9865894 | ||
| 0.174 | 0.045 | 0.174 | Nav1.2 sodium channel blocker | 0.14 0.063 CID_9865894 | ||
| 0.132 | 0.004 | 0.132 | Vasopressin 2 antagonist | 0.121 0.004 CID_9865894 | ||
| 0.133 | 0.006 | 0.133 | Estrogen-related receptor beta agonist | 0.094 0.034 CID_9865894 | ||
| 0.198 | 0.072 | 0.198 | Platelet adhesion inhibitor | 0.187 0.078 CID_9865894 | ||
| 0.167 | 0.042 | 0.167 | Acetylcholine antagonist | 0.122 0.069 CID_9865894 | ||
| 0.25 | 0.128 | 0.25 | Apoptosis antagonist | 0.25 0.127 CID_9865894 | ||
| 0.161 | 0.039 | 0.161 | Cholesterol synthesis inhibitor | |||
| 0.143 | 0.022 | 0.143 | Anabolic | 0.117 0.043 CID_9865894 | ||
| 0.16 | 0.041 | 0.16 | 5 Hydroxytryptamine 2 antagonist | 0.124 0.056 CID_9865894 | ||
| 0.138 | 0.019 | 0.164 | Transcription factor NF kappa B stimulant | 0.164 0.013 CID_9865894 | CID_9865894 | |
| 0.128 | 0.012 | 0.128 | Na+ K+ transporting ATPase inhibitor | 0.108 0.025 CID_9865894 | ||
| 0.156 | 0.044 | 0.156 | Nav1.3 sodium channel blocker | 0.135 0.059 CID_9865894 | ||
| 0.246 | 0.138 | 0.246 | Vasodilator, coronary | 0.208 0.174 CID_9865894 | ||
| 0.189 | 0.083 | 0.189 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.132 | 0.031 | 0.137 | Opioid antagonist | 0.137 0.03 CID_9865894 | CID_9865894 | |
| 0.118 | 0.023 | 0.118 | Analgesic, opioid | 0.094 0.034 CID_9865894 | ||
| 0.115 | 0.02 | 0.115 | Estrogen receptor alpha antagonist | 0.076 0.056 CID_9865894 | ||
| 0.13 | 0.038 | 0.13 | Estrogen antagonist | 0.113 0.069 CID_9865894 | ||
| 0.126 | 0.035 | 0.126 | 5 Hydroxytryptamine 2A antagonist | 0.088 0.054 CID_9865894 | ||
| 0.101 | 0.016 | 0.101 | Sigma receptor antagonist | 0.068 0.024 CID_9865894 | ||
| 0.11 | 0.028 | 0.111 | Opioid mu receptor antagonist | 0.111 0.028 CID_9865894 | CID_9865894 | |
| 0.131 | 0.05 | 0.131 | Microtubule formation inhibitor | 0.13 0.051 CID_9865894 | ||
| 0.162 | 0.082 | 0.173 | Antipruritic | 0.173 0.071 CID_9865894 | CID_9865894 | |
| 0.272 | 0.194 | 0.281 | Apoptosis agonist | 0.281 0.186 CID_9865894 | CID_9865894 | |
| 0.082 | 0.005 | 0.082 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.034 0.031 CID_9865894 | ||
| 0.199 | 0.122 | 0.303 | 5 Hydroxytryptamine release stimulant | 0.303 0.069 CID_9865894 | CID_9865894 | |
| 0.093 | 0.021 | 0.18 | Adrenaline uptake inhibitor | 0.18 0.007 CID_9865894 | CID_9865894 | |
| 0.107 | 0.049 | 0.107 | Prolactin inhibitor | |||
| 0.103 | 0.046 | 0.103 | Calcium antagonist | |||
| 0.061 | 0.007 | 0.061 | CXC chemokine 3 receptor antagonist | 0.051 0.009 CID_9865894 | ||
| 0.074 | 0.02 | 0.078 | Heme oxygenase stimulant | 0.078 0.016 CID_9865894 | CID_9865894 | |
| 0.118 | 0.066 | 0.118 | 5 Hydroxytryptamine antagonist | 0.102 0.077 CID_9865894 | ||
| 0.086 | 0.034 | 0.09 | Opioid delta receptor antagonist | 0.09 0.033 CID_9865894 | CID_9865894 | |
| 0.214 | 0.163 | 0.214 | Ca(v)3.3 blocker | |||
| 0.126 | 0.081 | 0.126 | Calcium channel blocker | |||
| 0.138 | 0.095 | 0.15 | Interferon gamma antagonist | 0.15 0.078 CID_9865894 | CID_9865894 | |
| 0.066 | 0.025 | 0.066 | Opioid agonist | 0.057 0.032 CID_9865894 | ||
| 0.102 | 0.061 | 0.102 | Estrogen receptor beta antagonist | |||
| 0.057 | 0.02 | 0.058 | Adenylate cyclase 1 inhibitor | 0.058 0.019 CID_9865894 | CID_9865894 | |
| 0.064 | 0.028 | 0.064 | Lipocortins synthesis agonist | 0.062 0.032 CID_9865894 | ||
| 0.053 | 0.017 | 0.06 | Parathyroid hormone antagonist | 0.06 0.011 CID_9865894 | CID_9865894 | |
| 0.111 | 0.077 | 0.111 | Acetylcholine muscarinic antagonist | |||
| 0.063 | 0.029 | 0.063 | Estrogen agonist | |||
| 0.109 | 0.077 | 0.109 | Adenylate cyclase inhibitor | |||
| 0.073 | 0.042 | 0.073 | Neuronal nicotinic receptor antagonist | 0.071 0.044 CID_9865894 | ||
| 0.057 | 0.03 | 0.073 | 5 Hydroxytryptamine 1B agonist | 0.073 0.016 CID_9865894 | CID_9865894 | |
| 0.044 | 0.019 | 0.044 | Farnesoid X receptor agonist | |||
| 0.053 | 0.029 | 0.053 | Squalene epoxidase inhibitor | |||
| 0.189 | 0.166 | 0.241 | Gastrin inhibitor | 0.241 0.09 CID_9865894 | CID_9865894 | |
| 0.103 | 0.08 | 0.103 | Acetylcholine release stimulant | |||
| 0.072 | 0.05 | 0.072 | Calcium channel L-type blocker | |||
| 0.153 | 0.133 | 0.153 | Hypolipemic | |||
| 0.049 | 0.03 | 0.049 | Opioid mu receptor agonist | 0.044 0.035 CID_9865894 | ||
| 0.039 | 0.021 | 0.039 | Estrogen receptor alpha agonist | |||
| 0.078 | 0.061 | 0.078 | Glycine receptor antagonist | |||
| 0.139 | 0.122 | 0.144 | Hepatoprotectant | 0.144 0.117 CID_9865894 | CID_9865894 | |
| 0.056 | 0.04 | 0.056 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.034 | 0.019 | 0.034 | RNA-directed RNA polymerase stimulant | 0.03 0.021 CID_9865894 | ||
| 0.043 | 0.03 | 0.043 | Opioid kappa receptor agonist | |||
| 0.132 | 0.12 | 0.132 | Interleukin 6 antagonist | |||
| 0.051 | 0.041 | 0.051 | Alpha 1L adrenoreceptor antagonist | |||
| 0.028 | 0.018 | 0.028 | Hedgehog signaling activator | 0.027 0.02 CID_9865894 | ||
| 0.057 | 0.049 | 0.124 | 5 Hydroxytryptamine uptake inhibitor | 0.124 0.02 CID_9865894 | CID_9865894 | |
| 0.051 | 0.044 | 0.053 | Bombesin 3 receptor antagonist | 0.053 0.041 CID_9865894 | CID_9865894 | |
| 0.153 | 0.147 | 0.153 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.05 | 0.045 | 0.05 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.083 | 0.08 | 0.083 | ABCA1 expression enhancer | 0.082 0.081 CID_9865894 | ||
| 0.154 | 0.151 | 0.154 | Vasodilator | |||
| 0.03 | 0.028 | 0.03 | Estrogen-related receptor beta antagonist | |||
| 0.014 | 0.013 | 0.014 | NMDA receptor phencyclidine site antagonist | |||
| 0.03 | 0.029 | 0.03 | Progesterone antagonist | |||
| 0.143 | 0.144 | 0.158 | Insulin sensitizer | 0.158 0.123 CID_9865894 | CID_9865894 | |
| 0.048 | 0.05 | 0.052 | Nicotinic alpha3beta2 receptor antagonist | 0.052 0.04 CID_9865894 | CID_9865894 | |
| 0.038 | 0.045 | 0.041 | Microtubule stabilization | 0.041 0.04 CID_9865894 | CID_9865894 | |
| 0.039 | 0.046 | 0.06 | Cannabinoid CB2 receptor antagonist | 0.06 0.03 CID_9865894 | CID_9865894 | |
| 0.18 | 0.19 | 0.21 | Transcription factor NF kappa B inhibitor | 0.21 0.159 CID_9865894 | CID_9865894 | |
| 0.26 | 0.271 | 0.315 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.315 0.193 CID_9865894 | CID_9865894 | |
| 0.058 | 0.084 | 0.07 | Phospholipase D inhibitor | 0.07 0.052 CID_9865894 | CID_9865894 | |
| 0.13 | 0.171 | 0.151 | Neurotrophic factor enhancer | 0.151 0.137 CID_9865894 | CID_9865894 | |
| 0.056 | 0.099 | 0.092 | Ornithine decarboxylase inhibitor | 0.092 0.054 CID_9865894 | CID_9865894 | |
| 0.098 | 0.155 | 0.13 | Vanilloid 1 agonist | 0.13 0.066 CID_9865894 | CID_9865894 | |
| 0.141 | 0.422 | 0.484 | Calcium channel L-type activator | 0.484 0.034 CID_9865894 | CID_9865894 | |
| 0.044 | 0.349 | 0.13 | Toll-Like receptor 3 antagonist | 0.13 0.023 CID_9865894 | CID_9865894 | |
| 0.103 | 0.408 | 0.18 | Peptidyltransferase inhibitor | 0.18 0.129 CID_9865894 | CID_9865894 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |